The official journal of the Brazilian Diabetes Society.
Differentiating among incretin-based therapies in the management of patients with type 2 diabetes mellitus
The glucagon-like peptide-1 receptor (GLP-1R) agonists and dipeptidyl peptidase-4 (DPP-4) inhibitors have become important options for the management of patients with type 2 diabetes mellitus. While the GLP-1R...